128 related articles for article (PubMed ID: 8842838)
1. Changing approach to gastroenteropancreatic tumours. Case report of a gastrinoma metastasis localized by somatostatin-receptor scintigraphy.
Fries W; Moschino P; Chierichetti F; Carniato S; Martines D; Martin A; Cecchetto A; Ricciardi G; Stracca-Pansa V; Naccarato R; Corsini A
Ital J Gastroenterol; 1996 May; 28(4):220-4. PubMed ID: 8842838
[TBL] [Abstract][Full Text] [Related]
2. 111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors.
Nauck C; Ivancević V; Emrich D; Creutzfeldt W
Z Gastroenterol; 1994 Jun; 32(6):323-7. PubMed ID: 7975760
[TBL] [Abstract][Full Text] [Related]
3. [Somatostatin receptor scintigraphy in neuroendocrine tumors exemplified by a patient with hepatic metastases of gastrinoma].
Behr T; Becker W; Koch W; Grebmeier J; Wolf F
Z Gastroenterol; 1994 Feb; 32(2):100-4. PubMed ID: 7513113
[TBL] [Abstract][Full Text] [Related]
4. [Imaging of somatostatin receptor using 111In-pentetreotide].
Kimura T; Sakahara H; Higashi T; Honda T; Konishi J; Hosotani R; Oshio G; Imamura M; Inokuma T
Kaku Igaku; 1996 Apr; 33(4):447-52. PubMed ID: 8683886
[TBL] [Abstract][Full Text] [Related]
5. Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma.
Schirmer WJ; Melvin WS; Rush RM; O'Dorisio TM; Pozderac RV; Olsen JO; Ellison EC
Surgery; 1995 Dec; 118(6):1105-13; discussion 1113-4. PubMed ID: 7491530
[TBL] [Abstract][Full Text] [Related]
6. A 7-year-old child with primary tumour localisation in the distal duodenum--new imaging procedures for an improved diagnosis.
Cholewa D; Waldschmidt J; Hoffmann K; Bäder M; Zimmer T; Scherübl H; Riecken EO; Wiedenmann B
Eur J Pediatr; 1997 Jul; 156(7):568-71. PubMed ID: 9243244
[TBL] [Abstract][Full Text] [Related]
7. 111In-pentetreotide detection of gastrinoma before and after surgery.
Scopinaro F; Schillaci O; Delle Fave G; Danieli R; Materia A; Tavolaro R; Angeletti S; Marignani M; Massa R; Gualdi G; Polettini E; Picardi V; Basso N
Anticancer Res; 1997; 17(3B):1757-60. PubMed ID: 9179230
[TBL] [Abstract][Full Text] [Related]
8. In-111 pentetreotide. Superior imaging agent for gastrinomas.
McCown JS; Gordon L; Uflacker RP
Clin Nucl Med; 1995 Oct; 20(10):896-8. PubMed ID: 8616995
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
10. Indium-111 pentetreotide uptake by pancreatic polypeptide cell hyperplasia: potential pitfall in somatostatin receptor scintigraphy.
Bunning J; Merchant SH; Crooks LA; Hartshorne MF
Pancreas; 2007 Nov; 35(4):372-5. PubMed ID: 18090246
[TBL] [Abstract][Full Text] [Related]
11. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
Kisker O; Bartsch D; Weinel RJ; Joseph K; Welcke UH; Zaraca F; Rothmund M
J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069
[TBL] [Abstract][Full Text] [Related]
12. [Somatostatin receptor scintigraphy in the primary diagnosis and follow-up care of gastrinoma].
Höring E; Räth U; Rücker S; von Gaisberg U; Meincke J; Walendzik J; Dörr U; Bihl H
Dtsch Med Wochenschr; 1994 Mar; 119(11):367-74. PubMed ID: 8131715
[TBL] [Abstract][Full Text] [Related]
13. [Value of endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localization of insulinomas and gastrinomas. Experience of 54 cases].
Mirallié E; Pattou F; Malvaux P; Filoche B; Godchaux JM; Maunoury V; Palazzo L; Lefebvre J; Huglo D; Paris JC; Carnaille B; Proye C
Gastroenterol Clin Biol; 2002 Apr; 26(4):360-6. PubMed ID: 12070411
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor scintigraphy in gastrinomas.
Jensen RT; Gibril F
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
[TBL] [Abstract][Full Text] [Related]
15. [Bone metastasis from gastrinoma without hepatic involvement. Utility of the scintigraphy with 111 In-pentetreotide].
Cortés M; Mora J; Benítez A; González MJ; Castell M; Martín-Comín J
Rev Esp Med Nucl; 2001 Feb; 20(1):23-6. PubMed ID: 11181326
[TBL] [Abstract][Full Text] [Related]
16. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison.
Cadiot G; Lebtahi R; Sarda L; Bonnaud G; Marmuse JP; Vissuzaine C; Ruszniewski P; Le Guludec D; Mignon M
Gastroenterology; 1996 Oct; 111(4):845-54. PubMed ID: 8831579
[TBL] [Abstract][Full Text] [Related]
17. Imaging of gastrinomas by nuclear medicine methods.
Béhé M; Gotthardt M; Behr TM
Wien Klin Wochenschr; 2007; 119(19-20):593-6. PubMed ID: 17985094
[TBL] [Abstract][Full Text] [Related]
18. Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Neuhaus C; Lenze H; Trautmann ME; Arnold R
Horm Metab Res Suppl; 1993; 27():28-35. PubMed ID: 8330869
[TBL] [Abstract][Full Text] [Related]
19. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
[TBL] [Abstract][Full Text] [Related]
20. Role of (111)In-DTPA-pentetreotide scintigraphy in accurate diagnosis of neuroendocrine gastroenteropancreatic tumors.
Ichijo T; Ishikawa M; Shimojo M; Tsubuku M; Tsuboi K; Miyachi Y
J Hepatobiliary Pancreat Surg; 2001; 8(5):473-8. PubMed ID: 11702259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
